Opko Health, Inc.
A Miami-based healthcare company that pairs one of the largest clinical reference laboratories in the United States with drug development, Opko Health makes the 4Kscore blood test, which gauges a man's risk of aggressive prostate cancer, and the kidney-disease treatment Rayaldee. It took shape in 2007 when biotech investor Phillip Frost merged three firms—Acuity Pharmaceuticals, Froptix, and eXegenics—into today's company. The name OPKO has no hidden meaning; it's simply a made-up brand Frost chose for the venture.
1.01 Entry into a Material Definitive Agreement · 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.07 Submission of Matters to a Vote of Security Holders
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits
7.01 Regulation FD Disclosure · 8.01 Other Events · 9.01 Financial Statements and Exhibits